Improve Medical(SZ:300030) Xin Lang Cai Jing·2025-09-23 02:43Group 1 - The core point of the news is that Yangpu Medical's stock has experienced a decline of 5.03% on September 23, with a total market value of 2.279 billion yuan and a trading volume of 36.18 million yuan, indicating a continuous downward trend over three days with a cumulative drop of 5.02% [1] - Yangpu Medical, established on August 19, 1996, and listed on December 25, 2009, is based in Zhuhai, Guangdong Province. The company specializes in providing technical solutions, products, and services for clinical testing laboratories and clinical care [1] - The main revenue composition of Yangpu Medical includes: vacuum blood collection systems (66.48%), reagents (12.23%), software products and services (10.03%), testing services (5.10%), other products (3.23%), instruments (2.81%), and microbiological transport systems (0.12%) [1] Group 2 - From the perspective of major fund holdings, Penghua Fund has one fund heavily invested in Yangpu Medical. The Penghua Smart Investment Digital Economy Mixed A Fund (020086) reduced its holdings by 31,800 shares in the second quarter, now holding 21,100 shares, which accounts for 0.62% of the fund's net value [2] - The fund has incurred a floating loss of approximately 8,229 yuan today, with a total floating loss of 8,651 yuan during the three-day decline [2] - The Penghua Smart Investment Digital Economy Mixed A Fund (020086) was established on May 17, 2024, with a latest scale of 5.1349 million yuan. Year-to-date returns are 44.8%, ranking 1,390 out of 8,172 in its category, while the one-year return is 100.02%, ranking 638 out of 7,995 [2]